FY 2004 (No.200-211)
Japanese
version
issued
on |
No. |
Table of contents |
PDF |
| March 31, 2005 |
211 |
- Important Safety Information
(1)Raloxifene Hydrochloride
(2)Quetiapine Fumarate
(3)Blood Glucose Self-monitoring Kit (those using the glucose dehydrogenase method and coenzyme pyroloquinoline quinone)
- Revision of PRECAUTIONS (No. 164)
Trandolapril (and 4 others)
|
Full text [321 KB] |
| February 24, 2005 |
210 |
- Leflunomide-related interstitial pneumon
- Important Safety Information
(1)Epirubicin Hydrochloride
(2)Freeze-dried Sulfonated Human Normal Immunoglobulin, pH4 Treated Acidic Human Normal Immunoglobulin, Polyethylene Glycol Treated Human Normal Immunoglobulin, Freeze-dried Polyethylene Glycol Treated Human Normal Immunoglobulin
(3)Telithromycin
(4)Prednisolone (oral dosage form)
(5)Mizoribine
- Revision of PRECAUTIONS (No. 163)
Mefenamic Acid (and 11 others)
|
Full text [485 KB] |
| January 27, 2005 |
209 |
- Important Safety Information
(1)Phtharal
- Revision of PRECAUTIONS (No. 162)
Lisinopril (and 8 others)
|
Full text [117 KB] |
| December 21, 2004 |
208 |
- Important Safety Information
(1)Interferon Alfa (NAMALWA)
(2)Telithromycin
- Revision of PRECAUTIONS (No. 161)
Amitriptyline Hydrochloride (and 13 others)
|
Full text [339 KB] |
| November 25, 2004 |
207 |
- Important Safety Information
(1)Paclitaxel
(2)Sodium Rabeprazole
- Revision of PRECAUTIONS (No. 160)
Flurbiprofen (oral dosage form) (and 13 others)
|
Full text [387 KB] |
| October 28, 2004 |
206 |
- Safety measures for shock etc. due to injectable antibiotics etc.
- Reports on Iressa Tablets 250 prospective study (special investigation)
- Safety measures for blood glucose monitoring kits
|
Full text [396 KB] |
| September 30, 2004 |
205 |
- Reports on adverse reactions associated with influenza vaccines in FY2003
- Post-marketing safety measures for ticlopidine hydrochloride products and Cypher Stent
- Important Safety Information
(1)Tacrolimus Hydrate (oral dosage form, injectable dosage form)
- Revision of PRECAUTIONS (No. 159)
Sevoflurane (and 14 others)
|
Full text [455 KB] |
| August 26, 2004 |
204 |
- Important Safety Information
(1)Argatroban
(2)Mosapride Citrate
(3)Salicylamide / Acetaminophen / Anhydrous Caffeine / Promethazine Methylenedisalicylate
(4)Concentrated Glycerin / Fructose
- Revision of PRECAUTIONS (No. 158)
Cabergoline (and 12 others)
|
Full text [363 KB] |
| July 29, 2004 |
203 |
- Serious skin disorders caused by pharmaceuticals
- Effects of electromagnetic waves from antitheft devices, etc. on medical devices
- Important Safety Information
(1)Monoethanolamine Oleate
(2)Clarithromycin
(3)Tegafur / Gimeracil / Oteracil Potassium
(4)Melphalan (injectable dosage form)
- Revision of PRECAUTIONS (No. 157)
Milnacipran Hydrochloride (and 6 others)
|
Full text [476 KB] |
| June 24, 2004 |
202 |
- Safety measures relating to pharmaceuticals with high risks resulting from mix-ups
- Important Safety Information
(1)Infliximab (Genetical recombination)
(2)Imatinib Mesilate
(3)Oseltamivir Phosphate
- Revision of PRECAUTIONS (No. 156)
Tandospirone Citrate (and 5 others)
|
Full text [5.3 MB] |
| May 27, 2004 |
201 |
- Important Safety Information
(1)Clofedanol Hydrochloride
(2)Flavoxate Hydrochloride
(3)Vinorelbine Ditartrate
(4)Phtharal
(5)Fluorouracil (injectable dosage form)
(6)Doxazosin Mesilate
(7)Sodium Risedronate Hydrate
- Revision of PRECAUTIONS (No. 155)
Lornoxicam (and 18 others)
|
Full text [324 KB] |
| April 22, 2004 |
200 |
- Prevention of overdose by use of OptiPen Pro-1 (insulin self-injection device)
- Crude drugs and drug products with possible adverse reaction when mistakenly imported due to the similarity in names
- Change of URL in response to the establishment of the Pharmaceuticals and Medical Devices Agency
- Health hazard caused by natural health foods and non-approved drugs
|
Full text [270 KB] |
